Solstein Capital’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.05M | Hold |
15,277
| – | – | 0.54% | 45 |
|
|
2025
Q1 | $1.06M | Sell |
15,277
-5,560
| -27% | -$386K | 0.62% | 40 |
|
|
2024
Q4 | $1.79M | Sell |
20,837
-5,000
| -19% | -$430K | 1% | 23 |
|
|
2024
Q3 | $3.08M | Sell |
25,837
-5,000
| -16% | -$595K | 1.63% | 13 |
|
|
2024
Q2 | $4.4M | Hold |
30,837
| – | – | 2.87% | 6 |
|
|
2024
Q1 | $3.96M | Sell |
30,837
-921
| -3% | -$118K | 2.75% | 7 |
|
|
2023
Q4 | $3.29M | Buy |
31,758
+28
| +0.1% | +$2.9K | 2.43% | 9 |
|
|
2023
Q3 | $2.89M | Hold |
31,730
| – | – | 2.48% | 9 |
|
|
2023
Q2 | $2.57M | Buy |
31,730
+380
| +1% | +$30.7K | 2.14% | 12 |
|
|
2023
Q1 | $2.49M | Sell |
31,350
-2,290
| -7% | -$182K | 2.17% | 13 |
|
|
2022
Q4 | $2.28M | Sell |
33,640
-3,528
| -9% | -$239K | 1.9% | 13 |
|
|
2022
Q3 | $1.85M | Buy |
37,168
+288
| +0.8% | +$14.4K | 1.63% | 14 |
|
|
2022
Q2 | $2.06M | Buy |
36,880
+386
| +1% | +$21.5K | 1.57% | 13 |
|
|
2022
Q1 | $2.03M | Sell |
36,494
-1,088
| -3% | -$60.4K | 1.33% | 19 |
|
|
2021
Q4 | $2.11M | Sell |
37,582
-782
| -2% | -$43.8K | 1.27% | 18 |
|
|
2021
Q3 | $1.84M | Buy |
38,364
+25,520
| +199% | +$1.23M | 1.06% | 23 |
|
|
2021
Q2 | $538K | Sell |
12,844
-90
| -0.7% | -$3.77K | 0.66% | 45 |
|
|
2021
Q1 | $436K | Buy |
12,934
+2,760
| +27% | +$93K | 0.59% | 55 |
|
|
2020
Q4 | $356 | Buy |
10,174
+1,054
| +12% | +$37 | 0.15% | 56 |
|
|
2020
Q3 | $317K | Sell |
9,120
-1,800
| -16% | -$62.6K | 0.71% | 41 |
|
|
2020
Q2 | $358K | Buy |
+10,920
| New | +$358K | 0.85% | 35 |
|